Disease | intestinal disease |
Comorbidity | C0023895|liver disease |
Sentences | 8 |
PubMedID- 21767410 | Background: primary sclerosing cholangitis (psc) is a rare chronic cholestatic liver disease often associated with inflammatory bowel diseases (ibd). |
PubMedID- 22545220 | The diagnostic criteria for nphpt were as follows: apart from normal serum calcium and high pth levels, serum 25ohd levels above 30 ng/ml, absence of bisphosphonates, thiazide diuretics, anticonvulsants or lithium use, glomerular filtration rate greater than 60 ml/min, using the formula modification of diet in renal disease (mdrd), and the absence of other metabolic bone diseases or gastrointestinal diseases associated with malabsorption or liver disease. |
PubMedID- 24363521 | Nonalcoholic fatty liver disease is associated with benign gastrointestinal disorders. |
PubMedID- 24895841 | National trends and inpatient outcomes of inflammatory bowel disease patients with concomitant chronic liver disease. |
PubMedID- 26024828 | Low-dose parenteral soybean oil for the prevention of parenteral nutrition-associated liver disease in neonates with gastrointestinal disorders: a multicenter randomized controlled pilot study. |
PubMedID- 23158500 | Risk factors of non-alcoholic fatty liver disease in patients with inflammatory bowel disease. |
PubMedID- 21692821 | Background: primary sclerosing cholangitis (psc) is a chronic cholestatic liver disease strongly associated with inflammatory bowel disease (ibd). |
PubMedID- 23075867 | Primary sclerosing cholangitis (psc) is a chronic inflammatory bile duct disease of unknown etiology, frequently associated with inflammatory bowel disease and leading to end-stage liver disease requiring liver transplantation. |
Page: 1